← Evidence map

ReviewNeuro-oncology2025

The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma.

Macarena I de la Fuente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39723472